Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $339,946 (100.0% shares, 0.0% debt)

Holdings (23)

ACRS Aclaris therapeutics 25.1%

Value ($000) $85,243 Shares 2,858,569 Est. Cost $19.11 Unrealized +50.9%

ASND Ascendis Pharma 14.6%

Value ($000) $49,471 Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Nabriva Therapeutics AG 14.2%

Value ($000) $48,259 Shares 4,021,559 Est. Cost $8.31 Unrealized —

CDXS Codexis, Inc. 7.5%

Value ($000) $25,415 Shares 5,294,825 Est. Cost $3.85 Unrealized +18.2%

— Eiger BioPharmaceuticals 6.0%

Value ($000) $20,462 Shares 1,787,091 Est. Cost $16.42 Unrealized —

— Advanced Accelerator Applications S.A. 5.7%

Value ($000) $19,284 Shares 483,786 Est. Cost $35.30 Unrealized —

— Aimmune Therapeutics, Inc. 4.9%

Value ($000) $16,580 Shares 763,009 Est. Cost $10.82 Unrealized —

— Strongbridge Biopharma plc 4.2%

Value ($000) $14,250 Shares 3,000,000 Est. Cost $2.40 Unrealized —

— Capnia, Inc. 3.1%

Value ($000) $10,434 Shares 14,695,264 Est. Cost $0.95 Unrealized —

— BioPharmX Corporation 1.9%

Value ($000) $6,471 Shares 12,814,286 Est. Cost $0.37 Unrealized —

— Trevena, Inc. 1.9%

Value ($000) $6,342 Shares 1,728,000 Est. Cost $7.67 Unrealized —

— Akari Therapeutics Plc 1.7%

Value ($000) $5,843 Shares 527,842 Est. Cost $14.00 Unrealized —

— Agile Therapeutics, Inc. 1.4%

Value ($000) $4,852 Shares 1,513,975 Est. Cost $6.21 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 1.3%

Value ($000) $4,404 Shares 600,000 Est. Cost $4.62 Unrealized 0.0%

— Foamix Pharmaceuticals Ltd. 1.2%

Value ($000) $4,232 Shares 855,000 Est. Cost $9.26 Unrealized —

— Sierra Oncology Inc. 1.1%

Value ($000) $3,731 Shares 2,438,270 Est. Cost $1.53 Unrealized —

CRSP CRISPR Therapeutics AG 1.0%

Value ($000) $3,241 Shares 148,878 Est. Cost $18.69 Unrealized +5.1%

RGNX Regenxbio Inc. 0.9%

Value ($000) $3,173 Shares 164,403 Est. Cost $12.80 Unrealized +50.7%

KALV KalVista Pharmaceuticals, Inc. 0.7%

Value ($000) $2,346 Shares 300,325 Est. Cost $7.37 Unrealized +1.9%

— Dynavax Technologies Corporation 0.6%

Value ($000) $2,141 Shares 359,828 Est. Cost $19.24 Unrealized —

— Sunesis Pharmaceuticals, Inc. 0.6%

Value ($000) $2,050 Shares 500,000 Est. Cost $3.62 Unrealized —

— ReVance Therapeutics, Inc. 0.5%

Value ($000) $1,609 Shares 77,373 Est. Cost $24.38 Unrealized —

— Capnia, Inc. 0.0%

Value ($000) $113 Shares 943,858 Est. Cost $0.23 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	Aclaris therapeutics	2,858,569	$85,243	25.1%	$19.11	+50.9%	Common	00461U105
ASND	Ascendis Pharma	1,766,832	$49,471	14.6%	$17.51	—	ADR	04351P101
—	Nabriva Therapeutics AG	4,021,559	$48,259	14.2%	$8.31	—	ADR	62957M104
CDXS	Codexis, Inc.	5,294,825	$25,415	7.5%	$3.85	+18.2%	Common	192005106
—	Eiger BioPharmaceuticals	1,787,091	$20,462	6.0%	$16.42	—	Common	28249U105
—	Advanced Accelerator Applications S.A.	483,786	$19,284	5.7%	$35.30	—	Sponsored ADS	00790T100
—	Aimmune Therapeutics, Inc.	763,009	$16,580	4.9%	$10.82	—	Common	00900T107
—	Strongbridge Biopharma plc	3,000,000	$14,250	4.2%	$2.40	—	Ordinary Shares	G85347105
—	Capnia, Inc.	14,695,264	$10,434	3.1%	$0.95	—	Common	14066L105
—	BioPharmX Corporation	12,814,286	$6,471	1.9%	$0.37	—	Common	09072X101
—	Trevena, Inc.	1,728,000	$6,342	1.9%	$7.67	—	Common	89532E109
—	Akari Therapeutics Plc	527,842	$5,843	1.7%	$14.00	—	ADR	00972G108
—	Agile Therapeutics, Inc.	1,513,975	$4,852	1.4%	$6.21	—	Common	00847L100
AUPH	Aurinia Pharmaceuticals Inc.	600,000	$4,404	1.3%	$4.62	0.0%	Common	05156V102
—	Foamix Pharmaceuticals Ltd.	855,000	$4,232	1.2%	$9.26	—	Common	M46135105
—	Sierra Oncology Inc.	2,438,270	$3,731	1.1%	$1.53	—	Common	82640U107
CRSP	CRISPR Therapeutics AG	148,878	$3,241	1.0%	$18.69	+5.1%	Namen AKT	H17182108
RGNX	Regenxbio Inc.	164,403	$3,173	0.9%	$12.80	+50.7%	Common	75901B107
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2,346	0.7%	$7.37	+1.9%	Common	483497103
—	Dynavax Technologies Corporation	359,828	$2,141	0.6%	$19.24	—	Common	268158201
—	Sunesis Pharmaceuticals, Inc.	500,000	$2,050	0.6%	$3.62	—	Common	867328700
—	ReVance Therapeutics, Inc.	77,373	$1,609	0.5%	$24.38	—	Common	761330109
—	Capnia, Inc.	943,858	$113	0.0%	$0.23	—	Warrant	14066L113